Literature DB >> 9238658

Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.

C T Taylor1, P M Johnson.   

Abstract

Human preimplantation embryos, gametes and cumulus cells were studied for expression of the complement-binding proteins CD46 (membrane cofactor protein), CD55 (decay accelerating factor) and CD59 (membrane attack complex inhibitory factor) as well as complement receptors type 1 (CRI), type 2 (CR2) and type 3 (CR3). Both the CD55 and CD59 glycosyl phosphatidylinositol (GPI)-anchored proteins were expressed by the plasma membrane and zona pellucida of oocytes, early embryos and expanded preimplantation blastocysts; in contrast, CD46 was expressed only on the plasma membrane. Cumulus cells consistently expressed CD46 and, most strongly, CD59 whereas CD55 expression was variable. Monoclonal antibodies (mAbs) to CRI, CR2 and CR3 epitopes gave only occasional reactivity on oocytes and were unreactive with blastocysts, spermatozoa and cumulus cells. CD46 is expressed only on the spermatozoal inner acrosomal membrane, and CD59 on the plasma membrane; CD55 expression was confirmed on the plasma membrane as well as the inner acrosomal membrane. Control mAbs specific for factor H were usually unreactive with gametes, blastocysts and cumulus cells. These data support the concept that gametes and early embryonic cells are protected from complement-mediated attack by expression of CD46, CD55 and CD59, although these complement-binding proteins may have additional roles in reproductive events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9238658     DOI: 10.1093/molehr/2.1.52

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  8 in total

1.  Human embryo culture: back to nature.

Authors:  H J Leese
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

2.  Sequence analysis of libraries from individual human blastocysts.

Authors:  G Morozov; O Verlinsky; S Rechitsky; V Kukharenko; E Goltsman; V Ivakhnenko; V Gindilis; C Strom; A Kuliev; Y Verlinsky
Journal:  J Assist Reprod Genet       Date:  1998-05       Impact factor: 3.412

3.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein).

Authors:  J A Cummerson; B F Flanagan; D G Spiller; P M Johnson
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

5.  Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm.

Authors:  Naokazu Inoue; Masahito Ikawa; Tomoko Nakanishi; Misako Matsumoto; Midori Nomura; Tsukasa Seya; Masaru Okabe
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.

Authors:  Alison Venable; Maisam Mitalipova; Ian Lyons; Karen Jones; Soojung Shin; Michael Pierce; Steven Stice
Journal:  BMC Dev Biol       Date:  2005-07-21       Impact factor: 1.978

7.  The bovine cumulus proteome is influenced by maturation condition and maturational competence of the oocyte.

Authors:  J Walter; C Monthoux; C Fortes; J Grossmann; B Roschitzki; T Meili; B Riond; R Hofmann-Lehmann; H Naegeli; U Bleul
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

8.  Complement in Human Pre-implantation Embryos: Attack and Defense.

Authors:  Martin P Reichhardt; Karolina Lundin; A Inkeri Lokki; Gaëlle Recher; Sanna Vuoristo; Shintaro Katayama; Juha S Tapanainen; Juha Kere; Seppo Meri; Timo Tuuri
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.